KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
1,092.00
-22.00 (-1.97%)
Aug 4, 2026, 10:04 AM JST
KYORIN Pharmaceutical Company Description
KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells generic drugs in Japan and internationally.
The company is also involved in drug discovery and licensing activities. It also offers infectious disease-related products; over-the-counter drug; and generic drugs.
The company was formerly known as KYORIN Holdings, Inc. KYORIN Pharmaceutical Co., Ltd. was founded in 1923 and is headquartered in Tokyo, Japan.
KYORIN Pharmaceutical Co., Ltd.
| Country | Japan |
| Founded | 1923 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,982 |
| CEO | Yutaka Ogihara |
Contact Details
Address: A Tokyo, 100-0004 Japan | |
| Phone | 81 3 6374 9700 |
| Website | kyorin-pharm.co.jp |
Stock Details
| Ticker Symbol | 4569 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3247090008 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yutaka Ogihara | Chief Executive Officer |
| Yasuji Kurose | Chief Financial Officer |